Ads
related to: covid-19 symptoms in adults
Search results
New clinical study of ‘next wave’ biotic shows versatile application potential
Nutraingredients.com· 2 days agoA well-functioning immune system is designed to prevent microbes, such as bacteria and viruses, from entering or harming the body. The gastrointestinal tract (GI) is another important line of ...
7 Best Cough Medicines for Kids, Ranked by Pharmacists 2024
US News Health· 3 days agoOver-the-counter cough medications help reduce the urge to cough, loosen mucus that may cause a cough, relieve a stuffy nose and decrease inflammation caused by infection. OTC cough medications ...
Ahead of Hajj, CDC alerts doctors to look out for meningococcal disease tied to travel to Saudi...
KTBS Shreveport· 23 hours agoSince April, there have been 12 confirmed cases of meningococcal disease associated with travel for Umrah, an Islamic pilgrimage to Mecca, the birthplace of the Prophet Muhammad in Saudi Arabia ...
HCC Screening of At-Risk Adults Improves Detection, Survival
Medscape· 7 days agoHepatocellular carcinoma screening was associated with earlier detection and improved survival, even...
Asthma, COPD often not diagnosed, study indicates
UPI· 2 days agoFinding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 13 hours agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung
Many treatments for alcohol use disorder exist but are rarely prescribed
UPI· 1 day agoMany effective treatments exist for alcohol use disorder, including psychotherapy, peer support...
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at...
Benzinga· 1 day agoDupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...
Benzinga· 1 day agoNOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved...
WTRF Wheeling· 8 hours agoIn Eli Lilly and Company's (NYSE: LLY) pivotal Phase 3 VIVID-1 study, patients with moderately to severely active Crohn's disease, with or without previous biologic failure, achieved statistically ...